Published in Vaccine Weekly, May 9th, 2001
The researchers, reporting the breakthrough in the new edition of BBSRC Business on April 5, 2001, hope that by understanding how the bacteria latch onto and colonize their host, they will be able to design novel drugs and vaccines against the bacteria. The team is focusing their research on the O157:H7 strain of E. coli, which caused the death of 21 people in Lanarkshire, Scotland, in 1996 and has more than 73,000 cases reported annually in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.